Neuropace, Inc. · NASDAQ:NPCE

Morrell Martha had 335 Neuropace, Inc. shares withheld for tax (Form 4)

Traded Sep 24, 2026 · Filed Sep 25, 2026

On Sep 24, 2026, Morrell Martha (CHIEF MEDICAL OFFICER) had 335 Neuropace, Inc. shares withheld for tax at US$13.97 for US$4,680, leaving 51,357 shares. Filed Sep 25, 2026 (Form 4).

Withheld for tax
335 shares
Price
US$13.97
Value
US$4,680
Holding after
51,357 shares
Trading plan
No
Role
CHIEF MEDICAL OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 24, 2026Common StockShares withheld for tax335US$13.9751,357Direct

Source

View original at SEC

Related